• M. DAVID RAJU Department of Chemistry, PB Siddhartha College of Arts and Science, Vijayawada, A. P.



HPLC, Choline salicylate, Tannic acid, Development, Validation


Objective: The current investigation was pointed at completely unique and reliable high performance liquid chromatographic method for simultaneous quantification of Choline salicylate and Tannic acid.

Methods: Chromatographic separation was achieved on a symmetry C18 column (150x4.6mm, 3.5 µ) using isocratic elution with a buffer containing 1 ml of OPA in l lt of HPLC marked water and acetonitrile within the percentage of 60:40 as movable phase with a flow rate of 1.0 ml/min at ambient temperature. Analysis was achieved within 15 min over an honest linearity within the concentration range from 4-60 µg/ml of choline salicylate and 2.5-37.5 µg/ml of tannic acid. Stress conditions of degradation in acidic, alkaline, peroxide and thermal was studied.

 Results: LOD and LOQ were observed as 1.21 µg/ml, 0.758 µg/ml and 4 µg/ml, 2.5 µg/ml of choline salicylate and tannic acid respectively. Precision and recovery study results were found to be within the suitable limit.

Conclusion: This developed method showed reliable, precise, accurate results under optimized conditions. The method was validated as reported by ICH guidelines. Hence it was evident that the proposed method was suitable for regular analysis and quality control of pharmaceutical preparations.


Download data is not yet available.


Trelle Sven, Reichenbach Stephan, Wandel Simon, Hildebrand Pius, Tschannen Beatrice, et al. Cardiovascular safety of non-steroidal anti-inflammatory drugs; network meta-analysis. BMJ (Critical research Ed.) 2011; 342: c7086.

Axelrod Y K, Diringer M N. Temperature management in acute neurologic disorders. Neurol Clin 2008; 26: 585-603.

Sullivan J E, Committee on H C, Sullivan J E, Farrar H C. Fever and anti-pyretic use in children. Pediatrics. 2011; 127: 580-7.

E Michael Sarrell MD, Eliahu Wielunsky MD, Herman Avner Cohen. Anti pyretic treatment in young children with fever; acetaminophen, ibuprofen or both alternating in a randomized double blind study. Arch Pediatr Adolesc Med 2006; 160: 197-202.

Smolen JS, van der Heijde D, Machold KP, Aletaha D, Landewe R. Proposal for a new nomenclature of disease modifying antirheumatic drugs. Ann Rheum Dis 2014; 73: 3-5.

Nandi P, Kingsley GH, Scott DL. Disease modifying antirheumatic drugs other than methotrexate in rheumatoid arthritis and seronegative arthritis. Curr Opin Rheumatol 2008; 20: 251-6.

Shekelle PG, Newberry SJ, Fitzgerald J D, Motala A, O Hanlon C E, et al. Management of gout: A systematic review in support of an American college of Physicians clinical practice guideline. Ann Intern med 2017; 166: 37-51.

Durme CM, Wechalekar MD, Landewe RB. Non steroidal anti inflammatory drugs for treatment of acute gout. JAMA 2015; 313: 2276-7.

Jones Duckett T. The diagnosis of rheumatic fever. JAMA 1944; 126: 481-4.

Karthikeyan Ganesan, Guilherme Luiza. Acute rheumatic fever. The Lancet 2018; 392(10142):161-174.

Singh JA, Cameron C, Noorbaloochi S, Cullis T, Tucker M, Christensen R et al. Risk of serious infection in biological treatment of patients with rheumatoid arthritis. A systematic review and meta-analysis. Lancet 2015; 386: 258-65.

Cutolo M, Kitas GD, van Reil PL. Burden of disease in treated rheumatoid arthritis patients; going beyond the joint. Semin Arthritis Rheum 2014; 43: 479-88.

Fleming PS, Fedorowicz Z, Johal A, El-Angbawi A, Pandis N, et al. Surgical adjunctive procedure for accelerating orthodontic treatment. Cochrane Database Syst Rev 2015; CD010572.

Millette DT, Cunningham SJ, O Brien KD, Benson PE, de Oliveira CM. Orthodontic treatment for deep bite and retroclined upper front teeth in children. Cochrane Database Syst Rev 2018; 2:CD005972.

Shim YJ, Doo H K, Ahn S Y, Seong J K, Park I S, Min B H. Inhibitory effect of aqueous extract from the gall of Rhus chinensis on alpha-glucosidace activity and post pandrial blood glucose. J Ethnopharmacol 2003; 85: 283-7.

Supriya T, Naresh D, Vijaya Kumar G, Haneer MA. Stability indicating RP-HPLC method development and validation for simultaneous estimation of escitalopram and flupentixol pure and marketed formulation. Asian J Pharm Res 2018; 8: 4-10.

Syed. Rafi, Kantipudi Rambabu. Stability indicating validated HPLC method for the determination of Aceclofenac and Misoprostol in bulk and pharmaceutical formulation. Int J Res Pharm Sci 2020; 11: 7848-53.

Shanmugasundaram P, Kamarapu S K. RP-HPLC method for the simultaneous estimation and validation of amlodipine besylate and atenolol in bulk and tablet dosage form in biorelevant dissolution medium (Fassif). Research J Pharm and Tech 2017;10:3379-85.

Manoranjani M. A study of method development, validation and forced degradation for simultaneous quantification of Cisplatin and Fluorouracil in bulk and pharmaceutical dosage form by RP-HPLC. J Pharm Sci Rev 2021; 13: 155-61.

Malathi S, Arunadevi N. Development and validation of stability-indicating simultaneous estimation of metformin and alogliptin in tablets by high-performance thin layer chromatography. Int J Pharm Pharm Sci 2020; 12: 68-73.

Subba Rao Yarlagadda, Subba Rao Mannam, Baby Padmini Jampani. Stability indicating and cost effective analytical method development and validation of Sotorasib by using RP-HPLC. Int J App Pharm 2021; 13: 154-159.

V L N Balaji Gupta T, Venkateswara Rao B, Kishore Babu B. RP-HPLC (stability indicating) based assay method for the simultaneous estimation of Doravirine, Tenofovir Disoproxil Fumarate and Lamivudine. Int J App Pharm 2021; 13: 153-9.

Gadhvi M.P, Bhandari A, Suhagia B.N, Desai U.H. Development and validation of RP-HPLC method for simultaneous estimation of atazanavir and ritonavir in their combined tablet dosage form. Research J Pharm and Tech 2013; 6:200-203.

Shivani C.P, Maheshwari D. G, Development and validation of UV spectrometric and HPLC method for estimation of escitalopram oxalate and flupentixol dihydrochloride in combined dosage form. AJPTI 2016; 4: 59-70.

Sri Girija K, Bikshal Babu K, Venkateswara Rao A. A new high performance liquid chromatography method for the separation and simultaneous quantification of Eptifibatide and its impurities in pharmaceutical injection formulation. Int J App Pharm 2021; 13: 165-72.

Swati K, Abhishek P, Sushank S, Bothiraja C, Atmaram P. High-performance liquid chromatography for the simultaneous estimation of cefoperazone and sulbactam in rat plasma and its importance in therapeutic drug monitoring. Int J Pharm Pharm Sci 2020; 12: 92-7.

Vijayakumari M, Balasekhar reddy Ch. Stability indicating validated hplc method for the determination of zanubrutinib in bulk and pharmaceutical dosage form. Asian J Pharm Clin Res 2020; 13: 159-62.

Rajakumari R, Sreenivasa Rao S, Stress degradation studies and development of a validated RP-HPLC method for determination of Tiagabine in presence of its degradation products. Int J Pharm Pharm Sci 2016; 8: 230-36.

International conference on the harmonization. ICH harmonized tripartite guideline. Validation of analytical procedures: Text and methodology Q2(R1); 2005.

Malak Y, Al-Bathish A. A, Gazy M. K. El-Jamal. Rp-hplc and chemometric methods for the determination of two anti-diabetic mixtures;metformin hydrochloride-canagliflozin and metformin hydrochloride-gliclazide in their pharmaceutical formulation. Int J Pharm Pharm Sci 2020; 12: 83-94.

Charu Pandya P, Sadhana Rajput J. Development and validation of stability indicating method RP-HPLC method of Acotiamide. Int J Pharm Pharm Sci 2018; 10: 1-8.

Birva Athavia A, Zarna Dedania R, Stability indicating HPLC method for determination of Vilazodone hydrochloride. Int J Curr Pharm Res 2017; 9: 123-9.



How to Cite




Original Article(s)